Logo for Beam Therapeutics Inc

Beam Therapeutics Investor Relations Material

Latest events

Logo for Beam Therapeutics

Q1 2024

7 May, 2024
Logo for Beam Therapeutics

Q4 2023

27 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Beam Therapeutics Inc

Access all reports
Segment Data
Access more data
Revenue by
License and collaboration revenue
Expenses by
Beam Therapeutics Inc. operates as a clinical-stage biotechnology company, which develops base editing technology to treat serious diseases by making precise changes to DNA and RNA. Its portfolio includes target genes that cover oncology, hematology, ophthalmology, liver disease and neurology conditions. The company was founded by David Nelles, Matthew Porteus and Feng Zhang on April 10, 2018 and is headquartered in Cambridge, MA.